BML Capital Management, LLC - ELIEM THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 24 filers reported holding ELIEM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,097,632
+15.0%
1,938,263
+22.4%
4.68%
+17.4%
Q2 2023$4,432,876
-7.8%
1,583,170
-4.5%
3.99%
-4.1%
Q1 2023$4,808,693
-28.2%
1,658,170
-9.1%
4.16%
-35.0%
Q4 2022$6,698,242–1,825,134–6.40%–
 Download
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,938,263$5,097,6324.68%
RA Capital Management 13,150,849$34,586,7330.68%
SILVERARC CAPITAL MANAGEMENT, LLC 121,110$318,5190.10%
Atom Investors LP 78,886$207,4700.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 811,680$2,134,7180.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 55,223$145,7890.00%
Chicago Partners Investment Group LLC 12,806$32,7850.00%
TUDOR INVESTMENT CORP ET AL 29,704$78,1220.00%
NORTHERN TRUST CORP 11,182$29,4090.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ELIEM THERAPEUTICS INC shareholders